Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Not yet recruiting"
topic_facet:"Medical Condition: Rheumatoid Arthritis MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Rheumatoid+Arthritis+MedDRA+version%3A+14.1Level%3A+PTClassification+code+10039073Term%3A+Rheumatoid+arthritisSystem+Organ+Class%3A+10028395+-+Musculoskeletal+and+connective+tissue+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Immune+System+Diseases+%5BC20%5D%22&lookfor=%22Arthritis%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Rheumatoid+Arthritis+MedDRA+version%3A+14.1Level%3A+PTClassification+code+10039073Term%3A+Rheumatoid+arthritisSystem+Organ+Class%3A+10028395+-+Musculoskeletal+and+connective+tissue+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Immune+System+Diseases+%5BC20%5D%22&lookfor=%22Arthritis%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Rheumatoid+Arthritis+MedDRA+version%3A+14.1Level%3A+PTClassification+code+10039073Term%3A+Rheumatoid+arthritisSystem+Organ+Class%3A+10028395+-+Musculoskeletal+and+connective+tissue+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Immune+System+Diseases+%5BC20%5D%22&lookfor=%22Arthritis%22&type=Subject
PubPharm (58)
1
A national, open-label, single-arm, phase IIIB study to evaluate the efficacy of weekly tocilizumab subcutaneous, administered as monotherapy or in combination with other non-biological medicinal products in rheumatoid arthritis (RA) patients. : A national, open-label, single-arm, phase IIIB study to evaluate the efficacy of weekly tocilizumab subcutaneous, administered as monotherapy or in combination with methotrexate and/or other DMARDS in rheumatoid arthritis (RA) patients.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
A national, open-label, single-arm, phase IIIB study to evaluate the efficacy of weekly tocilizumab subcutaneous, administered as monotherapy or in combination with other non-biological medicinal products in rheumatoid arthritis (RA) patients. : A national, open-label, single-arm, phase IIIB study to evaluate the efficacy of weekly tocilizumab subcutaneous, administered as monotherapy or in combination with methotrexate and/or other DMARDS in rheumatoid arthritis (RA) patients.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T) - SIRROUND-LTE : A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T) - SIRROUND-LTE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
4
A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T) - SIRROUND-LTE : A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T) - SIRROUND-LTE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
5
Alemtuzumab and rheumatoid arthritis - a study to look at the function of the immune system : Alemtuzumab and rheumatoid arthritis - an immunisation study - Alemtuzumab and rheumatoid arthritis - an immunisation study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
6
Alemtuzumab and rheumatoid arthritis - a study to look at the function of the immune system : Alemtuzumab and rheumatoid arthritis - an immunisation study - Alemtuzumab and rheumatoid arthritis - an immunisation study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
7
Long-term Safety and Efficacy of Sirukumab in Participants with RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 : A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T) - SIRROUND-LTE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2018
Wird geladen...
8
Long-term Safety and Efficacy of Sirukumab in Participants with RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 : A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T) - SIRROUND-LTE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2018
Wird geladen...
9
A Study of the Effectiveness and Safety of Ustekinumab (STELARA®) and CNTO 1959 Administered Under the Skin of Patients with Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy : A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy and Safety of Ustekinumab (STELARA®) and CNTO 1959 Administered Subcutaneously in Subjects with Active Rheumatoid Arthritis Despite Concomitant Methotrexate Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
10
A Study of the Effectiveness and Safety of Ustekinumab (STELARA®) and CNTO 1959 Administered Under the Skin of Patients with Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy : A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy and Safety of Ustekinumab (STELARA®) and CNTO 1959 Administered Subcutaneously in Subjects with Active Rheumatoid Arthritis Despite Concomitant Methotrexate Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2016
Wird geladen...
1
2
3
4
5
6
Nächster »
[6]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Filter aufheben
Thema: Medical Condition: Rheumatoid Arthritis MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Medienart
58
Aufsätze
58
E-Artikel
58
E-Ressourcen
Zeitschriftentitel
58
WHO International Clinical Trials Registry Plat...
Thema
58
610
Medical Condition: Rheumatoid Arthritis MedDRA ...
Recruitment Status: Not yet recruiting
58
Study Type: Interventional
6
Phase: Phase 3
2
Phase: Phase 2
2
Phase: Phase 4
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4
2020-
54
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
58
Englisch
Haven't found what you're looking for?
Wird geladen...